Legend Biotech Newsroom

Scotiabank Sticks to Their Buy Rating for Legend Biotech (LEGN)

TipRanksJul 18 07:39 ET

Buy Rating on Legend Biotech: Strong Carvykti Sales and High Market Potential Signal Upside

TipRanksJul 18 07:11 ET

Legend Biotech Analyst Ratings

BenzingaJul 18 06:11 ET

The Latest Analyst Ratings For Legend Biotech

BenzingaJul 15 13:00 ET

TD Cowen Adjusts Legend Biotech Price Target to $67 From $71, Maintains Buy Rating

MT NewswiresJul 15 12:22 ET

Legend Biotech Analyst Ratings

BenzingaJul 15 12:07 ET

Truist Financial Remains a Buy on Legend Biotech (LEGN)

TipRanksJul 15 07:19 ET

Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM), Legend Biotech (LEGN) and Intuitive Surgical (ISRG)

TipRanksJul 4 03:14 ET

Buy Rating Affirmed for Legend Biotech Amid Promising Carvykti Trial Results and Expert Endorsements

TipRanksJul 4 03:14 ET

Buy Rating on Legend Biotech: CARVYKTI's Clinical Success and Expanding Manufacturing Capacity

TipRanksJul 3 07:07 ET

Scotiabank Keeps Their Buy Rating on Legend Biotech (LEGN)

TipRanksJul 3 07:07 ET

Legend Biotech Analyst Ratings

BenzingaJul 3 06:24 ET

Legend Biotech Analyst Ratings

BenzingaJun 21 10:24 ET

Legend Biotech Analyst Ratings

BenzingaJun 17 06:43 ET

Legend Biotech Analyst Ratings

BenzingaJun 6 06:54 ET

Legend Biotech Analyst Ratings

BenzingaJun 4 06:27 ET

Jefferies Issues a Buy Rating on Legend Biotech (LEGN)

TipRanksMay 24 08:35 ET

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Merus (MRUS) and Agilon Health (AGL)

TipRanksMay 24 07:25 ET

Legend Biotech Analyst Ratings

BenzingaMay 23 13:02 ET

Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Singular Genomics Systems (OMIC)

TipRanksMay 15 08:08 ET